Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
ALPHARETTA, Ga., June 18, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced it has entered into an amendment to certain provisions of the two promissory notes dated August 1,...
-
ALPHARETTA, Ga., May 14, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), today announced the Company's upcoming financial conferences schedule: 2015 Marcum MicroCap Conference:...
-
ALPHARETTA, Ga., May 6, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), today reported financial results for the three months ended March 31, 2015 and provided a business update. The...
-
ALPHARETTA, Ga., May 6, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the independent Data Monitoring Committee (DMC) has performed an interim analysis on the...
-
ALPHARETTA, Ga., May 4, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) announced today that the Company will release financial results for the first quarter ended March 31, 2015, after...
-
ALPHARETTA, Ga., March 3, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), today reported financial results for the year ended December 31, 2014 and provided a business update. The Company...
-
ALPHARETTA, Ga., Feb. 26, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) announced today that the Company will release financial results for the year ended December 31, 2014, after the...
-
ALPHARETTA, Ga., Feb. 25, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) announced today the receipt of U.S. Pat. No. 8,961,441 from the U.S. Patent and Trademark Office entitled,...
-
Companies to Establish a Strategic Alliance and Joint Venture to Introduce the dermaPACE Device as a Preferred Treatment for Diabetic Foot Ulcers in the Gulf Cooperation Council Region SANUWAVE...
-
ALPHARETTA, Ga., Dec. 1, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company has enrolled its 130th patient in the Phase III supplemental clinical trial using...